Table 2 CD38 expression and IGHV gene mutational status in cases assigned to the +12,+19 subgroup (‘+12+19’) to cases exhibiting trisomy 12 yet without coexisting trisomy 19 (‘+12 non +19’) and cases negative for trisomy 12 (‘no +12’)
‘+12+19’ | ‘+12 non +19’ | ‘No +12’ | P-value | |
---|---|---|---|---|
CD38+ cells>30% | 16/19, 84.2% | 136/241, 56.4% | 111/561, 19.8% | <0.001 |
Median % of CD38+ cells | 95 | 72.5 | 55 | <0.05a |
IGHV gene identity to germline ⩾98% | 2/20, 10% | 115/218, 52.7% | 203/593, 34.2% | <0.001 |
IGHV gene identity to germline 100% | 0/20, 0% | 94/218, 43.1% | 145/593, 24.5% | <0.001 |